CEO of RNL Bio unveils tender offer

RNL Bio president Ra Jung-chan said last Friday that he will acquire a 50 percent stake of existing shareholders through tender offer. The tender offer is a public, open offer or invitation by a prospective acquirer to all stockholders of a publicly traded corporation to tender their stock for sale at a specified price during a specified time, subject to the tendering of a minimum and maximum n...